Protocol for a multi-centered, stepped wedge, cluster randomized controlled trial of the de-adoption of oral chlorhexidine prophylaxis and implementation of an oral care bundle for mechanically ventilated critically ill patients: the CHORAL study

Craig M Dale, Louise Rose, Sarah Carbone, Orla M Smith, Lisa Burry, Eddy Fan, Andre Carlos Kajdacsy-Balla Amaral, Victoria A McCredie, Ruxandra Pinto, Carlos R Quiñonez, Susan Sutherland, Damon C Scales, Brian H Cuthbertson, Craig M Dale, Louise Rose, Sarah Carbone, Orla M Smith, Lisa Burry, Eddy Fan, Andre Carlos Kajdacsy-Balla Amaral, Victoria A McCredie, Ruxandra Pinto, Carlos R Quiñonez, Susan Sutherland, Damon C Scales, Brian H Cuthbertson

Abstract

Background: Routine application of chlorhexidine oral rinse is recommended to reduce risk of ventilator-associated pneumonia (VAP) in mechanically ventilated patients. Recent reappraisal of the evidence from two meta-analyses suggests chlorhexidine may cause excess mortality in non-cardiac surgery patients and does not reduce VAP. Mechanisms for possible excess mortality are unclear. The CHORAL study will evaluate the impact of de-adopting chlorhexidine and implementing an oral care bundle (excluding chlorhexidine) on mortality, infection-related ventilator-associated complications (IVACs), and oral health status.

Methods: The CHORAL study is a stepped wedge, cluster randomized controlled trial in six academic intensive care units (ICUs) in Toronto, Canada. Clusters (ICU) will be randomly allocated to six sequential steps over a 14-month period to de-adopt oral chlorhexidine and implement a standardized oral care bundle (oral assessment, tooth brushing, moisturization, and secretion removal). On study commencement, all clusters begin with a control period in which the standard of care is oral chlorhexidine. Clusters then begin crossover from control to intervention every 2 months according to the randomization schedule. Participants include all mechanically ventilated adults eligible to receive the standardized oral care bundle. The primary outcome is ICU mortality; secondary outcomes are IVACs and oral health status. We will determine demographics, antibiotic usage, mortality, and IVAC rates from a validated local ICU clinical registry. With six clusters and 50 ventilated patients on average each month per cluster, we estimate that 4200 patients provide 80% power after accounting for intracluster correlation to detect an absolute reduction in mortality of 5.5%. We will analyze our primary outcome of mortality using a generalized linear mixed model adjusting for time to account for secular trends. We will conduct a process evaluation to determine intervention fidelity and to inform interpretation of the trial results.

Discussion: The CHORAL study will inform understanding of the effectiveness of de-adoption of oral chlorhexidine and implementation of a standardized oral care bundle for decreasing ICU mortality and IVAC rates while improving oral health status. Our process evaluation will inform clinicians and decision makers about intervention delivery to support future de-adoption if justified by trial results.

Trial registration: ClinicalTrials.gov, NCT03382730 . Registered on December 26, 2017.

Keywords: Chlorhexidine; Critical care; Mechanical ventilation; Oral care; Process evaluation; Stepped-wedge cluster randomized controlled trial; Ventilator-associated pneumonia.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Stepped-wedge schedule of the CHORAL study. Clusters sequentially cross over from control phase to intervention phase. Observational data collection is depicted during control (plus sign) and intervention (asterisks) periods

References

    1. Heyland DK, Cook DJ, Griffith L, Keenan SP, BrunBuisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159(4):1249–1256. doi: 10.1164/ajrccm.159.4.9807050.
    1. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D, for the VAP Guidelines Committee and the Canadian Critical Care Trials Group Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Prevention. J Crit Care. 2008;23(1):126–137. doi: 10.1016/j.jcrc.2007.11.014.
    1. Institute for Health Care Improvement . How-to guide: Prevent ventilator-associated pneumonia. 2012.
    1. NICE . Technical patient safety solutions for ventilator-associated pneumonia in adults. NICE. Technical patient safety solutions for ventilator-associated pneumonia in adults. 2008.
    1. Klompas M, Speck K, Howell Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med. 2014;174(5):751–761. doi: 10.1001/jamainternmed.2014.359.
    1. Price R, MacLennan G, Glen J, SuDDICU Collaboration Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ. 2014;348:g2197. doi: 10.1136/bmj.g2197.
    1. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vesin A, GarrousteOrgeas M, Decruyenaere J, Clec’h C, Azoulay E, Benoit D, Outcomerea Study G. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184(10):1133–1139. doi: 10.1164/rccm.201105-0867OC.
    1. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002;11:567+.
    1. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA. 2006;296(20):2460–2466. doi: 10.1001/jama.296.20.2460.
    1. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med. 2000;26(9):1239–1247. doi: 10.1007/s001340000585.
    1. Scannapieco FA, Yu J, Raghavendran K, Vacanti A, Owens SI, Wood K, Mylotte JM. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care. 2009;13(4):R117. doi: 10.1186/cc7967.
    1. Plantinga N, Wittekamp B, Leleu K, Depuydt P, Abeele A, Brun-Buisson C, Bonten M. Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU. Intensive Care Med. 2016;42(4):620–621. doi: 10.1007/s00134-016-4217-7.
    1. Kempen PM. A tale of silent aspiration: Are guidelines good for every patient? Anesth Analg. 2015;121(3):829–831. doi: 10.1213/ANE.0000000000000852.
    1. Adhikari NKJ, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–1346. doi: 10.1016/S0140-6736(10)60446-1.
    1. Sands KM, Wilson MJ, Lewis MAO, Wise MP, Palmer N, Hayes AJ, Barnes RA, Williams DW. Respiratory pathogen colonization of dental plaque, the lower airways, and endotracheal tube biofilms during mechanical ventilation. J Crit Care. 2017;37:30–37. doi: 10.1016/j.jcrc.2016.07.019.
    1. Dennesen P, van der Ven A, Vlasveld M, Lokker L. Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients. Crit Care Med. 2003;31:781–786. doi: 10.1097/01.CCM.0000053646.04085.29.
    1. Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, Jiang X, Day AG, Laporta D, Klompas M. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013;144(5):1453–1460. doi: 10.1378/chest.13-0853.
    1. Campbell GB, Happ MB. Symptom identification in the chronically critically ill. AACN Adv Crit Care. 2010;21(1):64–79.
    1. Puntillo K, Arai S, Cooper B, Stotts N, Nelson J. A randomized clinical trial of an intervention to relieve thirst and dry mouth in intensive care unit patients. Intensive Care Med. 2014;40(9):1295–1302. doi: 10.1007/s00134-014-3339-z.
    1. Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, Stelfox HT. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015;13:255. doi: 10.1186/s12916-015-0488-z.
    1. Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, DixonWoods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614. doi: 10.1136/bmj.k1614.
    1. Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:15. doi: 10.1186/1745-6215-14-15.
    1. Feider LL, Mitchell P. Validity and reliability of an oral care practice survey for the orally intubated adult critically ill patient. Nurs Res. 2009;58(5):374–377. doi: 10.1097/NNR.0b013e3181b4b3d1.
    1. Gelinas C, Fillion L, Puntillo K, Viens C, Fortier M. Validation of the Critical-Care Pain Observation Tool in adult patients. Am J Crit Care. 2006;15(4):420–427.
    1. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nurs. 1979;2(3):185–200. doi: 10.1097/00002820-197906000-00002.
    1. Ames NJ, Sulima P, Yates JM, McCullagh L, Gollins SL, Soeken K, Wallen GR. Effects of systematic oral care in critically ill patients: A multicenter study. Am J Crit Care. 2011;20(5):e103–e114. doi: 10.4037/ajcc2011359.
    1. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R, American College of Critical Care Medicine Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306. doi: 10.1097/CCM.0b013e3182783b72.
    1. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–1230. doi: 10.1016/S0140-6736(03)14546-1.
    1. Sinuff T, Muscedere J, Adhikari NKJ, Stelfox HT, Dodek P, Heyland DK, Rubenfeld GD, Cook DJ, Pinto R, Manoharan VH, Currie J, Cahill N, Friedrich J, Amaral A, Piquette D, Scales DC, Dhanani S, Garland A, for the KRITICAL Working Group, the Canadian Critical Care Trials Group, and the Canadian Critical Care Society Knowledge translation interventions for critically ill patients: A systematic review. Crit Care Med. 2013;41(11):2627–2640. doi: 10.1097/CCM.0b013e3182982b03.
    1. Price RJ, Cuthbertson BH. on behalf of the SuDDICU: Selective decontamination of the digestive tract and oropharynx: after 30 years of debate is the definitive answer in sight? Curr Opin Crit Care. 2016;22(2):161–166.
    1. Hemming K, Girling A, Martin J, Bond SJ. Stepped wedge cluster randomized trials are efficient and provide a method of evaluation without which some interventions would not be evaluated. J Clin Epidemiol. 2013;66:1058–1059. doi: 10.1016/j.jclinepi.2012.12.020.
    1. Woertman W, de Hoop E, Moerbeek M, Zuidema SU, Gerritsen DL, Teerenstra S. Stepped wedge designs could reduce the required sample size in cluster randomized trials. J Clin Epidemiol. 2013;66:752–758. doi: 10.1016/j.jclinepi.2013.01.009.
    1. Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405. doi: 10.1111/nhs.12048.

Source: PubMed

3
Prenumerera